These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 27266722)
21. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer. Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090 [TBL] [Abstract][Full Text] [Related]
22. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer. Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509 [TBL] [Abstract][Full Text] [Related]
23. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications. Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332 [TBL] [Abstract][Full Text] [Related]
24. Should small papillary thyroid cancer be observed? A population-based study. Nilubol N; Kebebew E Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528 [TBL] [Abstract][Full Text] [Related]
25. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506 [TBL] [Abstract][Full Text] [Related]
26. Treatment patterns of aging Americans with differentiated thyroid cancer. Park HS; Roman SA; Sosa JA Cancer; 2010 Jan; 116(1):20-30. PubMed ID: 19908255 [TBL] [Abstract][Full Text] [Related]
27. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. Adam MA; Pura J; Goffredo P; Dinan MA; Hyslop T; Reed SD; Scheri RP; Roman SA; Sosa JA J Clin Endocrinol Metab; 2015 Jan; 100(1):115-21. PubMed ID: 25337927 [TBL] [Abstract][Full Text] [Related]
28. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades. Goffredo P; Sosa JA; Roman SA World J Surg; 2013 Jul; 37(7):1599-605. PubMed ID: 23525600 [TBL] [Abstract][Full Text] [Related]
29. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Goffredo P; Roman SA; Sosa JA Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587 [TBL] [Abstract][Full Text] [Related]
30. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk? Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105 [No Abstract] [Full Text] [Related]
31. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer. Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414 [No Abstract] [Full Text] [Related]
32. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis. Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719 [TBL] [Abstract][Full Text] [Related]
33. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma. Wang J; Mao Y; Li L; Liang J; Huang H; Lin W; Chen G; Wen J Endocrine; 2024 Nov; 86(2):664-671. PubMed ID: 38809346 [TBL] [Abstract][Full Text] [Related]
34. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland. Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920 [TBL] [Abstract][Full Text] [Related]
35. Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer. Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA Ann Surg Oncol; 2016 Feb; 23(2):403-9. PubMed ID: 26416710 [TBL] [Abstract][Full Text] [Related]
36. Lymph node metastases in differentiated thyroid cancer under 2 cm. Reddy RM; Grigsby PW; Moley JF; Hall BL Surgery; 2006 Dec; 140(6):1050-4; discussion 1054-5. PubMed ID: 17188156 [TBL] [Abstract][Full Text] [Related]
37. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855 [TBL] [Abstract][Full Text] [Related]
38. Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines. Zhu Y; Gu WJ; Xiao WJ; Wang BH; Azizi M; Spiess PE; Ye DW Ann Surg Oncol; 2019 Feb; 26(2):685-691. PubMed ID: 30565040 [TBL] [Abstract][Full Text] [Related]
39. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. Adam MA; Pura J; Goffredo P; Dinan MA; Reed SD; Scheri RP; Hyslop T; Roman SA; Sosa JA J Clin Oncol; 2015 Jul; 33(21):2370-5. PubMed ID: 26077238 [TBL] [Abstract][Full Text] [Related]
40. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population. Sharma RK; Huang B; Lee JA; Kuo JH J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]